| WKN: | A12FMV |
| ISIN: | US0367521038 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Gesundheit |
Weshalb die Elevance Health-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 09. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2005 | 41,30 | 66,70 | 61,50% |
| 2 | 2021 | 254,10 | 409,10 | 61,00% |
| 3 | 2014 | 66,41 | 103,45 | 55,77% |
| 4 | 2013 | 45,19 | 66,41 | 46,96% |
| 5 | 2009 | 28,89 | 40,35 | 39,67% |
| 6 | 2004 | 29,80 | 41,30 | 38,59% |
| 7 | 2017 | 136,36 | 188,06 | 37,91% |
| 8 | 2015 | 103,45 | 128,44 | 24,16% |
| 9 | 2019 | 225,21 | 271,20 | 20,42% |
| 10 | 2011 | 42,64 | 51,14 | 19,93% |
| 11 | 2018 | 188,06 | 225,21 | 19,75% |
| 12 | 2022 | 409,10 | 475,30 | 16,18% |
| 13 | 2002 | 26,55 | 29,38 | 10,66% |
| 14 | 2016 | 128,44 | 136,36 | 6,17% |
| 15 | 2010 | 40,35 | 42,64 | 5,68% |
| 16 | 2003 | 29,38 | 29,80 | 1,43% |
| 17 | 2007 | 58,96 | 59,36 | 0,68% |
| 18 | 2020 | 271,20 | 254,10 | -6,31% |
| 19 | 2023 | 475,30 | 422,00 | -11,21% |
| 20 | 2006 | 66,70 | 58,96 | -11,60% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2008 | 59,36 | 28,89 | -51,33% |
| 2 | 2026 | 294,90 | 246,10 | -16,55% |
| 3 | 2024 | 422,00 | 352,30 | -16,52% |
| 4 | 2025 | 352,30 | 294,90 | -16,29% |
| 5 | 2012 | 51,14 | 45,19 | -11,63% |
| 6 | 2006 | 66,70 | 58,96 | -11,60% |
| 7 | 2023 | 475,30 | 422,00 | -11,21% |
| 8 | 2020 | 271,20 | 254,10 | -6,31% |
| 9 | 2007 | 58,96 | 59,36 | 0,68% |
| 10 | 2003 | 29,38 | 29,80 | 1,43% |
| 11 | 2010 | 40,35 | 42,64 | 5,68% |
| 12 | 2016 | 128,44 | 136,36 | 6,17% |
| 13 | 2002 | 26,55 | 29,38 | 10,66% |
| 14 | 2022 | 409,10 | 475,30 | 16,18% |
| 15 | 2018 | 188,06 | 225,21 | 19,75% |
| 16 | 2011 | 42,64 | 51,14 | 19,93% |
| 17 | 2019 | 225,21 | 271,20 | 20,42% |
| 18 | 2015 | 103,45 | 128,44 | 24,16% |
| 19 | 2017 | 136,36 | 188,06 | 37,91% |
| 20 | 2004 | 29,80 | 41,30 | 38,59% |